speb/financial-data huggingface dataset:
CRLA.PA — Peter Lynch category analysis (annual, as of 2023-12-31)
Lynch category: Asset Play (confidence: High)
Market cap (USD): 81929016
Net income (USD): 196507777.77777776
EPS growth %: -15.416667302648495
Revenue growth %: -1.5280782673532844
EPS 2-year CAGR %: -9.809071766043076
Smoothed growth %: -15.416667302648495
P/E ratio: 0.41692505470521385
P/B ratio: 0.014524466940323031
Pays dividend: no
Net asset value (USD): 5627814444.444445
Net cash (USD): -31938964444.444443
Net cash to market cap %: -38983.7032150422
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 3 (Weak)
CRLA.PA — Peter Lynch category analysis (annual, as of 2024-12-31)
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 93001687.5
Pays dividend: no
Net cash (USD): 527511458.3333334
Net cash to market cap %: 567.2063298134599
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
CRLA.PA — Peter Lynch category analysis (annual, as of 2025-12-31)
Lynch category: Asset Play (confidence: High)
Market cap (USD): 2199137882.352941
Net income (USD): 223087058.82352942
EPS 2-year CAGR %: 6.548494266335125
Smoothed growth %: 6.548494266335125
P/E ratio: 0.7189004524743704
P/B ratio: 0.022506962705059932
PEG ratio: 0.10978103106390961
Dividend yield: 0.03
Pays dividend: yes
Net asset value (USD): 7108443529.411765
Net cash (USD): -34915760000.00001
Net cash to market cap %: -1587.7021754835268
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 3 (Weak)
CRMD — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 633891279.28
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
CRMD — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 635460317.1
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
CRMD — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 483263648.56
Net income (USD): 20644000
P/E ratio: 5.852349938965317
P/B ratio: 4.206387496112738
Pays dividend: no
Net asset value (USD): 113095840
Net cash (USD): 42808172
Net cash to market cap %: 8.858140298273462
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 6.963398734310766 (Safe Zone)
Piotroski F-score: 3 (Weak)
CRMD — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 966527297.12
Net income (USD): 19827981
P/E ratio: 23.881393330363544
P/B ratio: 4.380757276519011
Pays dividend: no
Net asset value (USD): 218889927
Net cash (USD): 158742900
Net cash to market cap %: 16.424047253813995
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 17.92236703592318 (Safe Zone)
Piotroski F-score: 6 (Neutral)
CRMD — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 912395492.33
Net income (USD): 108562980
P/E ratio: 6.122023223329458
P/B ratio: 2.4387163310279867
Pays dividend: no
Net asset value (USD): -33397570
Net cash (USD): -321015261
Net cash to market cap %: -35.183784192118026
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 1.663484068768458 (Distress Zone)
Piotroski F-score: 4 (Weak)
CRMD — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 912395492.33
Net income (USD): 14020141
P/E ratio: 5.595626761375428
P/B ratio: 2.2511219700868725
Pays dividend: no
Net asset value (USD): -3767000
Net cash (USD): -272304000
Net cash to market cap %: -29.844952357733884
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 1.6734901416756247 (Distress Zone)
Piotroski F-score: 7 (Neutral)
CRMD — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 617416320
Net income (USD): 38601000
EPS growth %: 86.98411160627786
Revenue growth %: 226.0503556624533
Smoothed growth %: 86.98411160627786
P/E ratio: 3.1290322580645165
P/B ratio: 1.2188297877125907
PEG ratio: 0.035972457501522455
Pays dividend: no
Net asset value (USD): 38275000
Net cash (USD): -200501000
Net cash to market cap %: -32.47419828487851
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 1.529654851283307 (Distress Zone)
Piotroski F-score: 8 (Strong)
CRML — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Basic Materials | Industry: Other Industrial Metals & Mining
Lynch category: Cyclical (confidence: High)
Market cap (USD): 997374632.87
P/B ratio: 13.548633848516008
Pays dividend: no
Net asset value (USD): 73614406
Net cash (USD): -72567782
Net cash to market cap %: -7.275880056341742
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
CRML — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Basic Materials | Industry: Other Industrial Metals & Mining
Lynch category: Cyclical (confidence: High)
Market cap (USD): 525861735.74
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
CRML — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Basic Materials | Industry: Other Industrial Metals & Mining
Lynch category: Cyclical (confidence: High)
Market cap (USD): 853423616
P/B ratio: 7.084998973816025
Pays dividend: no
Net asset value (USD): 143882582
Net cash (USD): -42492503
Net cash to market cap %: -4.979063410403679
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
CRON — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Low)
Market cap (USD): 1464755192.8799999
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
CRON — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 949101579.0600001
Net income (USD): -124069117.64705881
P/B ratio: 1.131304885624437
Pays dividend: no
Net asset value (USD): 820697058.8235294
Net cash (USD): 592408823.5294118
Net cash to market cap %: 62.41785248278057
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 12.00467569169465 (Safe Zone)
Piotroski F-score: 2 (Weak)
CRON — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Speculative (confidence: Low)
Market cap (USD): 780953661.51
Net income (USD): -56032575.75757576
Revenue growth %: 13.370001605241907
Smoothed growth %: 13.370001605241907
P/B ratio: 0.9404582266177914
Pays dividend: no
Net asset value (USD): 816239393.9393939
Net cash (USD): 619231818.1818181
Net cash to market cap %: 79.29174913970091
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 15.336427719718483 (Safe Zone)
Piotroski F-score: 6 (Neutral)
CRON — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 754797318.78
Net income (USD): 28727272.72727273
Revenue growth %: 24.198246253621665
Smoothed growth %: 24.198246253621665
P/E ratio: 26.274590210696196
P/B ratio: 0.9715370418741256
Pays dividend: no
Net asset value (USD): 691855244.7552447
Net cash (USD): 561870629.3706294
Net cash to market cap %: 74.43993445535772
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 13.136300743739634 (Safe Zone)
Piotroski F-score: 7 (Neutral)
CRON — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Speculative (confidence: Low)
Market cap (USD): 982731162.5699999
Net income (USD): -2137956.204379562
EPS growth %: -107.44225261018201
Revenue growth %: 24.725129961342777
Smoothed growth %: -107.44225261018201
P/B ratio: 1.1779439968720664
Pays dividend: no
Net asset value (USD): 743451824.8175182
Net cash (USD): 567600729.9270072
Net cash to market cap %: 57.75747748169907
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 16.43882337590549 (Safe Zone)
Piotroski F-score: 7 (Neutral)
CRON.TO — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Low)
Market cap (USD): 1465225948.2047246
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
CRON.TO — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 945145157.4705882
Net income (USD): -124069117.64705881
P/B ratio: 1.1265889319557847
Pays dividend: no
Net asset value (USD): 820697058.8235294
Net cash (USD): 592408823.5294118
Net cash to market cap %: 62.67913651642942
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 11.95986425416311 (Safe Zone)
Piotroski F-score: 2 (Weak)
CRON.TO — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Speculative (confidence: Low)
Market cap (USD): 784124127.2954546
Net income (USD): -56032575.75757576
Revenue growth %: 13.370001605241907
Smoothed growth %: 13.370001605241907
P/B ratio: 0.9442762388470649
Pays dividend: no
Net asset value (USD): 816239393.9393939
Net cash (USD): 619231818.1818181
Net cash to market cap %: 78.97114712151871
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 15.393312521088607 (Safe Zone)
Piotroski F-score: 6 (Neutral)
CRON.TO — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 755163141.7552449
Net income (USD): 28727272.72727273
Revenue growth %: 24.198246253621665
Smoothed growth %: 24.198246253621665
P/E ratio: 26.28732455477118
P/B ratio: 0.9720079107582301
Pays dividend: no
Net asset value (USD): 691855244.7552447
Net cash (USD): 561870629.3706294
Net cash to market cap %: 74.40387358745546
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 13.141973545343829 (Safe Zone)
Piotroski F-score: 7 (Neutral)
CRON.TO — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Speculative (confidence: Low)
Market cap (USD): 981885649.9270073
Net income (USD): -2137956.204379562
EPS growth %: -107.44225261018201
Revenue growth %: 24.725129961342777
Smoothed growth %: -107.44225261018201
P/B ratio: 1.1769305289166105
Pays dividend: no
Net asset value (USD): 743451824.8175182
Net cash (USD): 567600729.9270072
Net cash to market cap %: 57.807213087308305
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 16.425995790727292 (Safe Zone)
Piotroski F-score: 7 (Neutral)
CRRX.TO — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Medical Care Facilities
Lynch category:  (confidence: Low)
Market cap (USD): 85065999.22962964
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
CRRX.TO — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Healthcare | Industry: Medical Care Facilities
Lynch category: Turnaround (confidence: High)
Market cap (USD): 89180770.74125873
Net income (USD): -1569930.06993007
P/B ratio: 1.5140867901410455
Pays dividend: no
Net asset value (USD): -14046853.146853147
Net cash (USD): -91067132.86713287
Net cash to market cap %: -102.11521173252368
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -0.4955771029167523 (Distress Zone)
Piotroski F-score: 3 (Weak)
CRRX.TO — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Medical Care Facilities
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 116689267.18881118
Net income (USD): 158741.25874125876
P/E ratio: 183.7727445814978
P/B ratio: 1.9313377710390167
Pays dividend: no
Net asset value (USD): -11028671.328671329
Net cash (USD): -88076223.77622378
Net cash to market cap %: -75.47928434044448
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -0.6059287271280687 (Distress Zone)
Piotroski F-score: 7 (Neutral)
CRRX.TO — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Medical Care Facilities
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 131988317.95620438
Net income (USD): 409489.05109489046
P/E ratio: 80.58110320855616
P/B ratio: 2.0797275964391697
Pays dividend: no
Net asset value (USD): -10001459.854014598
Net cash (USD): -89543065.69343065
Net cash to market cap %: -67.84165983776104
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -0.5224466381348771 (Distress Zone)
Piotroski F-score: 7 (Neutral)
CRRX.TO — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Medical Care Facilities
Lynch category:  (confidence: Low)
Market cap (USD): 162497393.4964029
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
CRRX.TO — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Medical Care Facilities
Lynch category: Turnaround (confidence: Low)
Market cap (USD): 175058190.13138682
Net income (USD): 17364233.576642334
Revenue growth %: 8.795659634088656
Smoothed growth %: 8.795659634088656
P/E ratio: 9.762082402038741
P/B ratio: 2.1901457524839274
Pays dividend: no
Net asset value (USD): 7740875.912408759
Net cash (USD): -87243795.62043795
Net cash to market cap %: -49.837025936894854
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.015385744565467263 (Distress Zone)
Piotroski F-score: 3 (Weak)
CRRX.TO — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Medical Care Facilities
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 154281243.16546765
Net income (USD): 841007.1942446043
EPS growth %: 429.7974835990238
Revenue growth %: 7.901530032255611
Smoothed growth %: 429.7974835990238
P/E ratio: 6.2405889242094705
P/B ratio: 2.143771522469722
PEG ratio: 0.014519835881662767
Dividend yield: 0.02
Pays dividend: yes
Net asset value (USD): 6415827.338129497
Net cash (USD): -88905035.97122303
Net cash to market cap %: -57.62530437732589
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -0.09978449893979391 (Distress Zone)
Piotroski F-score: 6 (Neutral)
CRS.L — Peter Lynch category analysis (annual, as of 2021-06-30)
Sector: Financial Services | Industry: Asset Management
Lynch category: Asset Play (confidence: High)
Market cap (USD): 479586.69444444444
Net income (USD): 48012765.277777776
P/E ratio: 0.009988733031096968
P/B ratio: 0.0028088899042289957
Pays dividend: no
Net asset value (USD): 170738872.22222224
Net cash (USD): 1226393.055555556
Net cash to market cap %: 255.71874069113107
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
CRS.L — Peter Lynch category analysis (annual, as of 2022-06-30)
Sector: Financial Services | Industry: Asset Management
Lynch category: Asset Play (confidence: High)
Market cap (USD): 500964.4024390244
Net income (USD): 10709120.731707318
EPS growth %: -77.69526360385677
Revenue growth %: -75.55033548617976
Smoothed growth %: -77.69526360385677
P/E ratio: 0.04677922819151535
P/B ratio: 0.0034032179222303234
Pays dividend: no
Net asset value (USD): 147203151.2195122
Net cash (USD): -276425.6097560976
Net cash to market cap %: -55.17869301896019
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
CRS.L — Peter Lynch category analysis (annual, as of 2023-06-30)
Sector: Financial Services | Industry: Asset Management
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 474771.9873417722
Net income (USD): -7058130.379746835
EPS growth %: -165.90765532084518
Revenue growth %: -149.9431069897269
Smoothed growth %: -165.90765532084518
P/B ratio: 0.004828601329425496
Pays dividend: no
Net asset value (USD): 98324950.63291138
Net cash (USD): 9804491.139240505
Net cash to market cap %: 2065.094698222493
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
CRS.L — Peter Lynch category analysis (annual, as of 2024-06-30)
Sector: Financial Services | Industry: Asset Management
Lynch category: Asset Play (confidence: High)
Market cap (USD): 648101.4430379746
Net income (USD): 72515260.75949366
EPS 2-year CAGR %: 160.21827833296805
Smoothed growth %: 160.21827833296805
P/E ratio: 0.008937448976257395
P/B ratio: 0.004040786264815634
PEG ratio: 5.578295478674071e-05
Pays dividend: no
Net asset value (USD): 160389934.1772152
Net cash (USD): 2660886.0759493667
Net cash to market cap %: 410.56629398577894
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 4 (Weak)
CRS.L — Peter Lynch category analysis (annual, as of 2025-06-30)
Sector: Financial Services | Industry: Asset Management
Lynch category:  (confidence: Low)
Market cap (USD): 1100987.876712329
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
CRSR — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Technology | Industry: Computer Hardware
Lynch category:  (confidence: Medium)
Market cap (USD): 2245595253.11
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
CRSR — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Technology | Industry: Computer Hardware
Lynch category: Speculative (confidence: Low)
Market cap (USD): 1450391603.27
Net income (USD): -53946000
P/B ratio: 2.2128720866937024
Pays dividend: no
Net asset value (USD): 59836000
Net cash (USD): -490631000
Net cash to market cap %: -33.8274848595263
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 2.5755263827313954 (Grey Zone)
Piotroski F-score: 3 (Weak)
CRSR — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Technology | Industry: Computer Hardware
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 1507039175.1
Net income (USD): 3187000
Revenue growth %: 6.16516059219052
Smoothed growth %: 6.16516059219052
P/E ratio: 472.8707797615312
P/B ratio: 2.1715887707138535
Pays dividend: no
Net asset value (USD): 124861000
Net cash (USD): -487863000
Net cash to market cap %: -32.37228388357109
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 2.762620232633955 (Grey Zone)
Piotroski F-score: 8 (Strong)
CRSR — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Technology | Industry: Computer Hardware
Lynch category: Turnaround (confidence: High)
Market cap (USD): 706491414.71
Net income (USD): -83394000
EPS growth %: -2716.6928145591464
Revenue growth %: -9.82933470331364
Smoothed growth %: -9.82933470331364
P/B ratio: 1.140510345773361
Pays dividend: no
Net asset value (USD): 85762000
Net cash (USD): -509366000
Net cash to market cap %: -72.09797449684284
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 1.7734283925553436 (Distress Zone)
Piotroski F-score: 4 (Weak)
CRSR — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Technology | Industry: Computer Hardware
Lynch category: Speculative (confidence: Low)
Market cap (USD): 634880333.34
Net income (USD): -12465000
Revenue growth %: 11.858362979050865
Smoothed growth %: 11.858362979050865
P/B ratio: 0.9831612864031815
Pays dividend: no
Net asset value (USD): 150582000
Net cash (USD): -510847000
Net cash to market cap %: -80.46350992044734
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 1.9513076614525993 (Grey Zone)
Piotroski F-score: 7 (Neutral)
CRSU.PA — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Asset Play (confidence: High)
Market cap (USD): 72773573.14583334
P/B ratio: 0.02074752736856954
Pays dividend: no
Net asset value (USD): 3493033333.3333335
Net cash (USD): -24576801041.666668
Net cash to market cap %: -33771.60139219276
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
CRSU.PA — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Asset Play (confidence: High)
Market cap (USD): 103163278.5647059
P/B ratio: 0.02484045312854099
Pays dividend: no
Net asset value (USD): 4136609411.764706
Net cash (USD): -27847867058.82353
Net cash to market cap %: -26993.972512570774
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
CRSU.PA — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Asset Play (confidence: High)
Market cap (USD): 1197038080
P/E ratio: 9.180556593666694
P/B ratio: 0.029198280256563174
Dividend yield: 0.03
Pays dividend: yes
Net asset value (USD): 4388767058.823529
Net cash (USD): -27958063529.411766
Net cash to market cap %: -2335.603519765367
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
CRT — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Energy | Industry: Oil & Gas E&P
Lynch category: Cyclical (confidence: High)
Market cap (USD): 46980000
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
CRT — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Energy | Industry: Oil & Gas E&P
Lynch category: Cyclical (confidence: High)
Market cap (USD): 115500000
Net income (USD): 11743236
P/E ratio: 9.835449104488745
P/B ratio: 38.99451544672353
Pays dividend: no
Net asset value (USD): 2961955
Net cash (USD): -3372
Net cash to market cap %: -0.0029194805194805197
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 47.20729255153682 (Safe Zone)
Piotroski F-score: 2 (Weak)
CRT — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Energy | Industry: Oil & Gas E&P
Lynch category: Cyclical (confidence: High)
Market cap (USD): 87360000
Net income (USD): 11547888
EPS growth %: -1.6634937763321798
Revenue growth %: -1.549185443222827
Smoothed growth %: -1.6634937763321798
P/E ratio: 7.565019681520985
P/B ratio: 32.69971398979556
Pays dividend: no
Net asset value (USD): 2671583
Net cash (USD): -5062
Net cash to market cap %: -0.005794413919413919
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 39.56895153460211 (Safe Zone)
Piotroski F-score: 5 (Neutral)
CRT — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Energy | Industry: Oil & Gas E&P
Lynch category: Cyclical (confidence: High)
Market cap (USD): 53160000
Net income (USD): 5677818
EPS growth %: -50.83241195273109
Revenue growth %: -46.641600900670035
EPS 2-year CAGR %: -30.466059884305462
Smoothed growth %: -50.83241195273109
P/E ratio: 9.362751676788513
P/B ratio: 21.846479577075826
Pays dividend: no
Net asset value (USD): 2433344
Net cash (USD): -4211
Net cash to market cap %: -0.007921369450714822
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 30.129649271767832 (Safe Zone)
Piotroski F-score: 3 (Weak)
CRT — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Energy | Industry: Oil & Gas E&P
Lynch category: Cyclical (confidence: High)
Market cap (USD): 46140000
Net income (USD): 4490844
EPS growth %: -20.905460513176013
Revenue growth %: -12.569171911712878
EPS 2-year CAGR %: -37.63905281126172
Smoothed growth %: -20.905460513176013
P/E ratio: 10.274237982882505
P/B ratio: 21.376747806265698
Pays dividend: no
Net asset value (USD): 2158420
Net cash (USD): -4554
Net cash to market cap %: -0.009869960988296489
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 18.09862979401088 (Safe Zone)
Piotroski F-score: 2 (Weak)
CRTM.L — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Basic Materials | Industry: Other Industrial Metals & Mining
Lynch category: Cyclical (confidence: High)
Market cap (USD): 139924.84824999998
Pays dividend: no
Net asset value (USD): -841313.75
Net cash (USD): -7335686.25
Net cash to market cap %: -5242.590105864203
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
CRTM.L — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Basic Materials | Industry: Other Industrial Metals & Mining
Lynch category: Cyclical (confidence: High)
Market cap (USD): 111521.67232876713
Pays dividend: no
Net asset value (USD): -1716989.0410958903
Net cash (USD): -8353006.849315069
Net cash to market cap %: -7490.030121401257
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
CRTM.L — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Basic Materials | Industry: Other Industrial Metals & Mining
Lynch category: Cyclical (confidence: High)
Market cap (USD): 10245110.810810812
P/E ratio: 0.0010771641206423817
P/B ratio: 0.03577775914772517
Pays dividend: no
Net asset value (USD): 5147925.675675675
Net cash (USD): -1500495.945945946
Net cash to market cap %: -14.645970879715598
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 3 (Weak)
CRTO — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Communication Services | Industry: Advertising Agencies
Lynch category:  (confidence: Medium)
Market cap (USD): 2021839766.48
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
CRTO — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Communication Services | Industry: Advertising Agencies
Lynch category:  (confidence: Low)
Market cap (USD): 1987673488.1200001
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
CRTO — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Communication Services | Industry: Advertising Agencies
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 1779158701.07
Net income (USD): 43490217.391304344
P/E ratio: 10.227350009899778
P/B ratio: 1.4877044606651662
Pays dividend: no
Net asset value (USD): 416519565.2173913
Net cash (USD): -776693478.2608695
Net cash to market cap %: -43.65509820983142
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 1.7532530674484486 (Distress Zone)
Piotroski F-score: 4 (Weak)
CRTO — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Communication Services | Industry: Advertising Agencies
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 1203858866.92
Net income (USD): 26964705.88235294
P/E ratio: 17.086937448558917
P/B ratio: 0.9075461248558789
Pays dividend: no
Net asset value (USD): 463501176.47058827
Net cash (USD): -897675294.117647
Net cash to market cap %: -74.56648937713894
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 1.4226404197014524 (Distress Zone)
Piotroski F-score: 5 (Neutral)
CRTO — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Communication Services | Industry: Advertising Agencies
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 1135526310.2
Net income (USD): 47149411.76470588
P/E ratio: 9.655480045268614
P/B ratio: 0.8242948712612207
Pays dividend: no
Net asset value (USD): 515984705.88235295
Net cash (USD): -720692941.1764705
Net cash to market cap %: -63.467744842436545
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 1.554915503727255 (Distress Zone)
Piotroski F-score: 8 (Strong)
CRTO — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Communication Services | Industry: Advertising Agencies
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 1035539701.47
Net income (USD): 56049411.76470588
P/E ratio: 5.9632442174964835
P/B ratio: 0.7423355136371801
Pays dividend: no
Net asset value (USD): 543054117.6470588
Net cash (USD): -764938823.5294118
Net cash to market cap %: -73.86861386806736
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 1.3996599468665631 (Distress Zone)
Piotroski F-score: 7 (Neutral)
CRTO — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Communication Services | Industry: Advertising Agencies
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 1026998208
Net income (USD): 9862068.965517242
EPS growth %: -77.32347742301901
Revenue growth %: -0.529525859841066
Smoothed growth %: -77.32347742301901
P/E ratio: 8.417840375586854
P/B ratio: 0.6702120264278906
Pays dividend: no
Net asset value (USD): 519040229.88505745
Net cash (USD): -637110344.8275862
Net cash to market cap %: -62.03616908624501
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 1.3628112256639788 (Distress Zone)
Piotroski F-score: 5 (Neutral)
CRWN.L — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Lynch category: Asset Play (confidence: High)
Market cap (USD): 1603559.986875
P/B ratio: 0.013854846957620529
Pays dividend: no
Net asset value (USD): 115740000
Net cash (USD): 18235000
Net cash to market cap %: 1137.1573342595163
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
CRWN.L — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Lynch category: Asset Play (confidence: High)
Market cap (USD): 229099718.9189189
P/B ratio: 0.010020058030274625
Pays dividend: no
Net asset value (USD): 173010810.8108108
Net cash (USD): 53297297.2972973
Net cash to market cap %: 23.26379864139416
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
CSAI — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Technology | Industry: Software - Infrastructure
Lynch category:  (confidence: Low)
Pays dividend: no
Net cash (USD): 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
CSAI — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Technology | Industry: Software - Infrastructure
Lynch category: Speculative (confidence: Low)
Net income (USD): -1245000
Pays dividend: no
Net asset value (USD): -504000
Net cash (USD): -1067000
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 3 (Weak)
CSAI — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Technology | Industry: Software - Infrastructure
Lynch category: Speculative (confidence: Low)
Market cap (USD): 110965554.48
Net income (USD): -2014000
P/B ratio: 16.11232096413533
Pays dividend: no
Net asset value (USD): 6887000
Net cash (USD): 5786000
Net cash to market cap %: 5.2142306926811655
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 52.44119560927856 (Safe Zone)
Piotroski F-score: 3 (Weak)
CSAI — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Technology | Industry: Software - Infrastructure
Lynch category: Speculative (confidence: Low)
Market cap (USD): 55232854.82
Net income (USD): -2010000
P/B ratio: 6.852711516129032
Pays dividend: no
Net asset value (USD): 8060000
Net cash (USD): 6731000
Net cash to market cap %: 12.186587171595342
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 26.518401337614332 (Safe Zone)
Piotroski F-score: 5 (Neutral)
CSAI — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Technology | Industry: Software - Infrastructure
Lynch category: Speculative (confidence: Low)
Market cap (USD): 31490224.92
Net income (USD): -2062000
P/B ratio: 4.635687460621228
Pays dividend: no
Net asset value (USD): 6793000
Net cash (USD): 4511000
Net cash to market cap %: 14.32508027954727
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.6460150358945542 (Grey Zone)
Piotroski F-score: 4 (Weak)
CSAI — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Technology | Industry: Software - Infrastructure
Lynch category: Speculative (confidence: Low)
Market cap (USD): 20243716.02
Net income (USD): -1834000
Revenue growth %: 306.3636363636364
Smoothed growth %: 306.3636363636364
P/B ratio: 2.272022
Pays dividend: no
Net asset value (USD): 8910000
Net cash (USD): 7241000
Net cash to market cap %: 35.769124566093375
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 3.536510197102283 (Safe Zone)
Piotroski F-score: 5 (Neutral)
CSAI — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Technology | Industry: Software - Infrastructure
Lynch category: Turnaround (confidence: High)
Market cap (USD): 6101982
Net income (USD): -2774000
Revenue growth %: 78.42605156037992
Smoothed growth %: 78.42605156037992
P/B ratio: 2.986925474137931
Pays dividend: no
Net asset value (USD): 5104000
Net cash (USD): 3079000
Net cash to market cap %: 50.45901479224292
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -8.553654457968824 (Distress Zone)
Piotroski F-score: 3 (Weak)
CSBBANK.NS — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Financial Services | Industry: Banks - Regional
Lynch category:  (confidence: Low)
Market cap (USD): 634326348.3809127
P/B ratio: 1.2825226925312685
Pays dividend: no
Net asset value (USD): 494592689.91877687
Net cash (USD): -3823044672.718586
Net cash to market cap %: -602.6936580006053
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
CSBBANK.NS — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 597789714.9113082
Net income (USD): 22263268.64624737
P/E ratio: 6.712735272725439
P/B ratio: 1.1369049533862416
Pays dividend: no
Net asset value (USD): 525804477.43745613
Net cash (USD): -4636720890.8113165
Net cash to market cap %: -775.6441395950162
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 2 (Weak)
CSBBANK.NS — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 781944916.3831033
Net income (USD): 13877837.584835012
P/E ratio: 14.086216811572514
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
CSBBANK.NS — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 709818755.022548
Net income (USD): 18075535.51296505
P/E ratio: 13.09226710082021
P/B ratio: 1.3395114678136892
Pays dividend: no
Net asset value (USD): 529908680.94701236
Net cash (USD): -4722842164.599774
Net cash to market cap %: -665.3588865019141
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 2 (Weak)
CSBBANK.NS — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 866739001.80127
Net income (USD): 17006795.14314359
P/E ratio: 12.169294823192478
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
CSBBANK.NS — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 644880516.8291649
Net income (USD): 21362865.62102586
EPS growth %: -4.044343351052709
Revenue growth %: -7.223992127199157
Smoothed growth %: -4.044343351052709
P/E ratio: 0.09847944269832633
P/B ratio: 1.1738478382107427
Pays dividend: no
Net asset value (USD): 518681644.7647308
Net cash (USD): -5164841034.336583
Net cash to market cap %: -800.8989106589493
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 2 (Weak)
CSBBANK.NS — Peter Lynch category analysis (quarterly, as of 2026-06-30)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 609504245.0891443
Net income (USD): 15828673.910750078
EPS growth %: 14.057206780160335
Revenue growth %: 2.188837849511277
Smoothed growth %: 14.057206780160335
P/E ratio: 0.0935619469562538
PEG ratio: 0.006655799293519864
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
CSBR — Peter Lynch category analysis (quarterly, as of 2024-10-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 54297489.660000004
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
CSBR — Peter Lynch category analysis (quarterly, as of 2025-01-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: Low)
Market cap (USD): 152616217.74
Net income (USD): 4495000
P/E ratio: 8.48810999666296
P/B ratio: 27.90568984092156
Pays dividend: no
Net asset value (USD): 5134000
Net cash (USD): -21956000
Net cash to market cap %: -14.38641340031416
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 1.106018188944766 (Distress Zone)
Piotroski F-score: 3 (Weak)
CSBR — Peter Lynch category analysis (quarterly, as of 2025-04-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 99290805.9
Net income (USD): -1835000
P/B ratio: 26.323119273594912
Pays dividend: no
Net asset value (USD): 3437000
Net cash (USD): -18787000
Net cash to market cap %: -18.92118794858125
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: -1.1328051706767743 (Distress Zone)
Piotroski F-score: 4 (Weak)
CSBR — Peter Lynch category analysis (quarterly, as of 2025-07-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 87764740.32000001
Net income (USD): -466000
P/E ratio: 40.0021605834093
P/B ratio: 24.806314392312043
Pays dividend: no
Net asset value (USD): 3173000
Net cash (USD): -16683000
Net cash to market cap %: -19.0087727020805
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: -1.3960270021227406 (Distress Zone)
Piotroski F-score: 6 (Neutral)
CSBR — Peter Lynch category analysis (quarterly, as of 2025-10-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 94985889.84
Net income (USD): 299000
P/E ratio: 38.10103884476534
P/B ratio: 22.449985781139212
Pays dividend: no
Net asset value (USD): 3835000
Net cash (USD): -17415000
Net cash to market cap %: -18.33430210459141
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: -1.0345538077868408 (Distress Zone)
Piotroski F-score: 7 (Neutral)
CSBR — Peter Lynch category analysis (quarterly, as of 2026-01-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 85126248
Net income (USD): -279000
EPS growth %: -106.20689655172413
Revenue growth %: -2.8170667292681495
Smoothed growth %: -106.20689655172413
P/B ratio: 23.187002754682503
Pays dividend: no
Net asset value (USD): 3948000
Net cash (USD): -16942000
Net cash to market cap %: -19.902204546827907
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: -1.2951240248825702 (Distress Zone)
Piotroski F-score: 4 (Weak)
CSIQ — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Technology | Industry: Solar
Lynch category:  (confidence: Medium)
Market cap (USD): 2124489276.21
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
CSIQ — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Technology | Industry: Solar
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 2098009544.1
Net income (USD): 219525735.29411763
P/E ratio: 9.557009529152083
P/B ratio: 1.2369620677801214
Pays dividend: no
Net asset value (USD): 1414786029.4117646
Net cash (USD): -4227205882.3529406
Net cash to market cap %: -201.48649438896234
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 1.4596584576397147 (Distress Zone)
Piotroski F-score: 4 (Weak)
CSIQ — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Technology | Industry: Solar
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 1780931726.27
Net income (USD): 275480303.030303
EPS growth %: 25.488841962523523
Revenue growth %: 5.030814828916486
Smoothed growth %: 25.488841962523523
P/E ratio: 6.464824187717321
P/B ratio: 0.6344602079313534
PEG ratio: 0.25363349960043735
Pays dividend: no
Net asset value (USD): 1923875757.5757575
Net cash (USD): -4736232575.757575
Net cash to market cap %: -265.9412770234143
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 1.1436871913491968 (Distress Zone)
Piotroski F-score: 5 (Neutral)
CSIQ — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Technology | Industry: Solar
Lynch category: Turnaround (confidence: High)
Market cap (USD): 755011848.88
Net income (USD): 25210489.510489512
EPS growth %: -90.84853282315565
Revenue growth %: -27.335837898242726
EPS 2-year CAGR %: -66.11184545773787
Smoothed growth %: -90.84853282315565
P/E ratio: 29.948321652614347
P/B ratio: 0.2601730597569089
Pays dividend: no
Net asset value (USD): 1947184615.3846154
Net cash (USD): -5356825174.825175
Net cash to market cap %: -709.5021333468607
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 0.7139784352930022 (Distress Zone)
Piotroski F-score: 3 (Weak)
CSIQ — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Technology | Industry: Solar
Lynch category: Turnaround (confidence: High)
Market cap (USD): 1613905723.73
Net income (USD): -76004379.56204379
EPS growth %: -401.4791899634479
Revenue growth %: -2.5571559944974327
Smoothed growth %: -2.5571559944974327
P/B ratio: 0.5178556168148841
Pays dividend: no
Net asset value (USD): 2026270072.9927006
Net cash (USD): -6957432846.715328
Net cash to market cap %: -431.09289126477375
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 0.6467398973550342 (Distress Zone)
Piotroski F-score: 2 (Weak)
CSL.AX — Peter Lynch category analysis (annual, as of 2021-06-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Medium)
Market cap (USD): 95227866140.10524
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
CSL.AX — Peter Lynch category analysis (annual, as of 2022-06-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 83294353092.4207
Net income (USD): 1554965517.2413793
P/E ratio: 53.56668824411673
P/B ratio: 8.285152597085236
Pays dividend: no
Net asset value (USD): 8234068965.5172415
Net cash (USD): -2298000000
Net cash to market cap %: -2.7588905065991858
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 6.9658532636240516 (Safe Zone)
Piotroski F-score: 2 (Weak)
CSL.AX — Peter Lynch category analysis (annual, as of 2023-06-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 83406802806.23842
Net income (USD): 1486092715.2317882
EPS growth %: -4.429217319994105
Revenue growth %: 20.5604616493172
Smoothed growth %: -4.429217319994105
P/E ratio: 56.12489850152407
P/B ratio: 7.065200955762372
Pays dividend: no
Net asset value (USD): -437086092.7152318
Net cash (USD): -11165562913.907284
Net cash to market cap %: -13.386873178493486
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 5.379068339088224 (Safe Zone)
Piotroski F-score: 3 (Weak)
CSL.AX — Peter Lynch category analysis (annual, as of 2024-06-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 90597375440.69333
Net income (USD): 1809333333.3333333
EPS growth %: 21.751039809863325
Revenue growth %: 12.250898233895056
EPS 2-year CAGR %: 7.869560890610816
Smoothed growth %: 7.869560890610816
P/E ratio: 50.07224140053058
P/B ratio: 7.004590647958352
PEG ratio: 6.362774505026302
Pays dividend: no
Net asset value (USD): 678000000
Net cash (USD): -11309333333.333334
Net cash to market cap %: -12.483069491054547
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 5.778242594365366 (Safe Zone)
Piotroski F-score: 7 (Neutral)
CSL.AX — Peter Lynch category analysis (annual, as of 2025-06-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Stalwart (confidence: High)
Market cap (USD): 35752500873.202614
Net income (USD): 2049673202.6143792
EPS growth %: 13.283338390625236
Revenue growth %: 2.977882780069139
EPS 2-year CAGR %: 17.440896804270146
Smoothed growth %: 17.440896804270146
P/E ratio: 17.299905994863025
P/B ratio: 5.228724610262063
PEG ratio: 0.9919160802916624
Dividend yield: 0.04
Pays dividend: yes
Net asset value (USD): 2058823529.4117646
Net cash (USD): -10352941176.470589
Net cash to market cap %: -28.95725032827109
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 3.3077516366115023 (Safe Zone)
Piotroski F-score: 7 (Neutral)